中集天达(0445.HK)通过私有化建议,市场价将持续向要约价0.266港元收拢
格隆汇12月28日丨中集天达于24日公布,有关根据公司法第86条由联席要约人透过计划安排将该公司私有化的建议已获法院会议及股东特别大会批准,预期将自2021年1月25日下午四时正起撤销股份于联交所的上市地位。同时,预期将在2021年1月15日前后,独立股东将收到要约款项。截止至24日,中集天达报于每股0.255港元收盘,仍较已获法院会议及股东特别大会批准的私有化建议的要约价0.266港元低超4%,业内人士指出,随着中集天达的私有化条件齐备及退市日期渐近,预期市场交易价格将向私有化价格收拢,仍然存在可观的低风险套利机会。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.